Clinical Trial Update: An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer [Phase 1]

View source ↗

Summary

This document reports on an exploratory pharmacogenomic study of cetuximab monotherapy in patients with metastatic colorectal cancer conducted in Phase 1, which…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED